MARTHA BENAVIDES: Open Payments
NPI 1215105580 · MODESTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,178 in 18 payments from 12 companies in 2025. Trend: 2023 $1,515 · 2024 $1,257 · 2025 $2,178
Food & beverage: $2,178
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $530 |
| Teva Pharmaceuticals USA, Inc. | 2 | $252 |
| Tandem Diabetes Care, Inc. | 2 | $196 |
| Mallinckrodt Hospital Products Inc. | 2 | $192 |
| Sequel Med Tech, LLC | 1 | $142 |
| SPR Therapeutics, Inc | 1 | $133 |
| Incyte Corporation | 1 | $131 |
| Daiichi Sankyo Inc. | 1 | $125 |
| Novo Nordisk Inc | 1 | $123 |
| Neurocrine BioSciences, Inc. | 1 | $121 |
Products named: TEZSPIRE, t:slim X2 Insulin Pump with Control-IQ, TERLIVAZ, TWIIST, SPRINT PNS System, AJOVY, Yeztugo, VIVITROL.
Industry payments across CA — which companies pay providers there.
